TikTok turns off political ads ahead of midterm elections
source link: https://finance.yahoo.com/video/tiktok-turns-off-political-ads-151301267.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
TikTok turns off political ads ahead of midterm elections
Yahoo Finance Live anchors discuss steps TikTok is taking ahead of the November midterms.
TikTok turns off political ads ahead of midterm elections
Yahoo Finance Live anchors discuss steps TikTok is taking ahead of the November midterms.
Investor's Business DailyHow To Lock In $75,000 Worth of 9.62% Treasury I Bonds
You have just a few weeks to pounce on Treasury I bonds' sky-high interest rate. Also called Series I savings bonds, their interest rate is 9.62%.
5h ago
Yahoo Finance VideoStocks turn lower, chip stocks Nvidia and AMD dip
Yahoo Finance Live’s Brad Smith discusses how stocks are trading following the Fed’s 75-basis-point rate hike.
1h ago
Motley FoolInsiders Are Loading Up on These 2 Beaten-Down Stocks
The market has soured on these stocks, but insiders are buying. Is it time to load up on these companies?
2h ago
Investor's Business DailyThe 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales
Eli Lilly's blockbuster potential diabetes drug Mounjaro is "de-risked and transformative," an analyst said Thursday as he updated LLY stock.
1h ago
Motley Fool1 Growth Stock Down 94% to Buy Right Now
The retreat is being driven by soaring inflation and rising interest rates, which are putting the brakes on the economy and forcing investors to rethink their growth expectations. Upstart Holdings (NASDAQ: UPST), for example, uses artificial intelligence (AI) to originate loans for banks on other lenders, and investors have doubts about how well its lending models will hold up as household finances deteriorate. Upstart's main goal is to displace the standard tools used to size up the risk in consumer lending.
5h ago
Motley Fool2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
The bear market hasn't dragged down Axsome Therapeutics (NASDAQ: AXSM). The biotech company specializes in treating central nervous system conditions. And it's been on a roll with good news -- and share performance -- in recent weeks.
5h ago
ZacksPlug Power (PLUG) Dips More Than Broader Markets: What You Should Know
Plug Power (PLUG) closed the most recent trading day at $25.52, moving -1.85% from the previous trading session.
18h ago
MarketWatchS&P 500 sees its third leg down of more than 10%. Here’s what history shows about past bear markets hitting new lows from there, according to Bespoke.
Stocks fell sharply after the Federal Reserve announced Wednesday that it was raising its benchmark rate by three quarters of a percentage point as it battles inflation, with the S&P 500 continuing a slide described by Bespoke Investment Group as its third leg down.
17h ago
MarketWatchThe Fed raised rates — retirees and near-retirees should do this
Retirees have to watch their spending, especially after the Federal Reserve’s latest rate hike announced on Wednesday. For the third time in a row, the Federal Reserve said on Wednesday it would raise the benchmark federal-funds rate – this time, by a 0.75 percentage point so that it hovers between 3% to 3.25%. The news may seem unsettling for retirees, in particular, many of whom are living on fixed incomes.
19h ago
ZacksEnergy Transfer LP (ET) Stock Moves -0.59%: What You Should Know
In the latest trading session, Energy Transfer LP (ET) closed at $11.86, marking a -0.59% move from the previous day.
18h ago
CNW GroupRECONAFRICA ENTERS INTO DEFINITIVE PURCHASE AND SALE AGREEMENT WITH NAMCOR AND ANNOUNCES WARRANT EXTENSION
Reconnaissance Energy Africa Ltd. (the "Company" or "ReconAfrica") (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) wishes to announce that, further to its announcement on February 6, 2022, it has entered into a definitive purchase and sale agreement with its partner, Namcor Exploration and Production (Pty) Ltd. ("NAMCOR") dated September 21, 2022, to acquire half of NAMCOR's 10% carried participating interest in the approximate 6.3 million acres petroleum exploration licence (PEL 73) in the Kavango
3h ago
Motley FoolGeneral Electric Investors Will Be Rewarded for Their Patience
Near-term storm clouds are gathering, but the stock looks like an excellent value for investors willing to ride out the volatility.
2h ago
MarketWatchCarl Icahn to investors: ‘The worst is yet to come’
Wall Street icon Carl Icahn has a warning for his fellow investors: “The worst is yet to come.” Speaking on Wednesday at MarketWatch’s Best New Ideas in Money festival via a remote feed, the 86-year-old Icahn delivered that grim assessment of the economy, but also spoke of areas of opportunity for investors.
18h ago
Insider MonkeySemiconductor Stocks: 10 Biggest Losers in September
In this article, we discuss semiconductor stocks and the 10 biggest losers in September. If you want to read about some more semiconductor stocks, go directly to Semiconductor Stocks: 5 Biggest Losers in September. Semiconductor stocks have started free falling as recession fears and concerns about softening demand hit the industry. The worsening macro environment […]
2h ago
TheStreet.comPowell Has Pretty Much Sealed the Fate of the Short-Term Stock Market
Here's what I see ahead -- and key areas of the S&P 500 -- as Powell and Co. punch back at inflation.
5h ago
MarketWatchUBS: LIlly's Type 2 diabetes and obesity treatment could be 'one of the best-selling drugs in history'
Shares of Eli Lilly & Co. Inc. gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying Mounjaro, the company's newly approved Type 2 diabetes drug, could be "the biggest drug ever." UBS analysts predict peak sales of $25 billion if the therapy is also approved as a treatment for weight management in people with obesity. "Tirzepatide's robust efficacy in both obesity and [Type 2 diabetes] should drive sales into a range that we believe could see this
3h ago
Motley Fool2 Cheap Dow Jones Stocks to Buy Hand Over Fist, and 1 to Avoid
This year's market slump created several growth stock bargains. But not every apparent bargain is what it seems.
2h ago
Motley FoolDo Back-to-Back Approvals Make This Biotech Stock a Buy Now?
This drugmaker has earned two new drug approvals in as many months, but its success isn't reflected in its market valuation yet.
6h ago
TipRanksMorgan Stanley Says These 3 Reliable Dividend Stocks Should Be on Your Buy List (Especially Right Now)
The major investment bank Morgan Stanley has been sounding alerts about the increasingly difficult economic conditions for several months now, and the firm’s chief US equity strategist Mike Wilson headed up a recent note on the topic of defensive investing, especially dividend investing. Wilson lays out a clear strategy for dividend investors, starting with the fact that the best dividend stocks, by their nature, provide an income stream that is both secure and stable, and will provide protectio
21h ago
MarketWatchJeffrey Gundlach says bonds are ‘wickedly cheap’ compared to stocks — and offers one way to get a 9% return without much risk
The bond king, Jeffrey Gundlach, is now very favorably disposed toward the asset class he knows best.
1d ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK